| Place of Origin: | China |
|---|---|
| Brand Name: | HNB |
| Certification: | ISO |
| Model Number: | Tadalafil |
| Minimum Order Quantity: | 1KG |
| Price: | Negotiable |
| Packaging Details: | Aluminum foil bag |
| Delivery Time: | Usually3-5days |
| Payment Terms: | L/C, D/A, D/P, T/T, Western Union, MoneyGram，Alibaba Assurance Order |
| Supply Ability: | 5000kg/Month |
| CAS: | 171596-29-5 | Mf: | C22H19N3O4 |
|---|---|---|---|
| MW: | 389.404 | Specification: | 99% |
| Einecs No.: | N/A | Appearance: | White Or Off-white Powder |
| Sample: | Available | Boiling Point: | 679.1℃ |
| High Light: | 99% Sexual Enhancement Powder,Sexual Enhancement Tadalafil Powder,CAS 171596-29-5 Tadalafil Citrate Powder |
||
Sexual Enhancement Powder Tadalafil Powder CAS 385769-84-6 For sell
|
Product name |
Tadalafil |
|
Appearance |
White or off-white powder |
|
CAS |
171596-29-5 |
|
MF |
C22H19N3O4 |
|
Purity |
99% |
|
Storage |
Keep in cool dry place. |
The Introductction of Tadalafil
Tadalafil, a selective and reversible inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase 5 (PDE5). When sexual stimulation results in the local release of nitric oxide, PDE5 is inhibited by tadalafil, increasing cGMP levels in the corpus cavernosum, which causes smooth muscle relaxation and blood flow into penile tissue, resulting in an erection, as in asexual stimulation.
The Application & Function of Tadalafil
Applicable symptoms
Erectile dysfunction and pulmonary hypertension.
The recommended dose of this product is 10mg, which is taken before sexual activity and is not affected by food. If the effect of taking 10mg is not significant, you can take 20mg, at least 30 minutes before sex.
Clinical studies have shown that tadalafil can enhance the antihypertensive effect of nitrates. This is thought to be the result of the combined action of nitrates and tadalafil on the nitric oxide/cGMP pathway. Therefore, it is contraindicated in patients taking any form of nitrates.
| Product Name | CAS No. | Product Name | CAS No. |
| Lufenuron | 103055-07-8 | Toltrazuril | 69004-03-1 |
| Nitenpyram | 120738-89-8 | Praziquantel/Biltricide | 55268-74-1 |
| Fenbendazole | 43210-67-9 | Tetramisole Hcl | 5086-74-8 |
| Levamisole | 14769-73-4 | Ponazuril | 9004-4-2 |
| Diclazuril | 101831-37-2 | Florfenicol | 73231-34-2 |
| Ivermectin | 70288-86-7 | Enrofloxacin Hcl | 112732-17-9 |
| Albendazole | 54965-21-8 | Mebendazole | 31431-39-7 |
The COA of Amino Tadalafil
| PRODUCT NAME: Tadalafil | |||
| BATCH NO.:HNB2022071601 | CAS No:171596-29-5 | ||
| STANDARD:EP 9(EP 9 Specification) | |||
| ITEM OF ANALYSIS | STANDARD | RESULT | |
| Appearance | White or almost white crystalline powder | White crystalline powder | |
|
Solubility |
Practically insoluble in water, freely soluble in dimethyl sulfoxide, slightly soluble in methylene chloride |
Conforms |
|
| Melting point | 302℃~303℃ | 303℃ | |
| Identification |
The infrared absorption spectrum is concordant with the reference spectrum |
Conforms | |
| Identification | The principal peak in the chromatogram obtained with the test solution is similar in retention time and size to the principal peak in the chromatogram obtained with reference solution | Conforms | |
| Rotation | + 78.0°to + 84.0° | +80.6° | |
| Impurities A, B and C | Impurity A, B and C≤0.1% | Non-detected | |
| Loss on drying | ≤0.5% | 0.2% | |
| Residue on ignition | ≤0.1% | 0.01% | |
| Heavy metals | ≤10ppm | Conforms | |
| Related Substances | individual impurity≤0.1% | 0.08% | |
| Related Substances | Total unknown impurity≤1.0% | 0.10% | |
|
Residual Solvents |
Methanol;≤0.3% | Non-detected | |
| Residual Solvents | IPA≤0.5% | Non-detected | |
| Residual Solvents | Methyl acetate≤0.5% | Non-detected | |
| Residual Solvents | EA≤0.5% | Non-detected | |
| Residual Solvents | DCM≤0.06% | Non-detected | |
| Residual Solvents | AceticAcid≤0.5% | Non-detected | |
| Assay(Dry based) | ≥99.0% | 99.7% | |
| Conclusion | The test results conform with EP 9 Specification. | ||
